106 related articles for article (PubMed ID: 37598351)
1. Unequal effects of SARS-CoV-2 infections: model of SARS-CoV-2 dynamics in Cameroon (Sub-Saharan Africa) versus New York State (United States).
Siewe N; Yakubu AA
J Biol Dyn; 2023 Dec; 17(1):2246496. PubMed ID: 37598351
[TBL] [Abstract][Full Text] [Related]
2. Hybrid discrete-time-continuous-time models and a SARS CoV-2 mystery: Sub-Saharan Africa's low SARS CoV-2 disease burden.
Siewe N; Yakubu AA
J Math Biol; 2023 May; 86(6):91. PubMed ID: 37149541
[TBL] [Abstract][Full Text] [Related]
3. Mathematical modeling of COVID-19 pandemic in the context of sub-Saharan Africa: a short-term forecasting in Cameroon and Gabon.
Nkwayep CH; Bowong S; Tsanou B; Alaoui MAA; Kurths J
Math Med Biol; 2022 Feb; 39(1):1-48. PubMed ID: 35045180
[TBL] [Abstract][Full Text] [Related]
4. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
[TBL] [Abstract][Full Text] [Related]
5. Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from Cameroon.
Fokam J; Essomba RG; Njouom R; Okomo MA; Eyangoh S; Godwe C; Tegomoh B; Otshudiema JO; Nwobegahay J; Ndip L; Akenji B; Takou D; Moctar MMM; Mbah CK; Ndze VN; Maidadi-Foudi M; Kouanfack C; Tonmeu S; Ngono D; Nkengasong J; Ndembi N; Bissek AZK; Mouangue C; Ndongo CB; Epée E; Mandeng N; Kamso Belinga S; Ayouba A; Fernandez N; Tongo M; Colizzi V; Halle-Ekane GE; Perno CF; Ndjolo A; Ndongmo CB; Shang J; Esso L; de-Tulio O; Diagne MM; Boum Y; Mballa GAE; Njock LR;
Sci Rep; 2023 Dec; 13(1):21654. PubMed ID: 38066020
[TBL] [Abstract][Full Text] [Related]
6. Viral co-infection with human respiratory syncytial virus in suspected acute and severe respiratory tract infections during COVID-19 pandemic in Yaoundé, Cameroon, 2020-2021.
Moumbeket Yifomnjou MH; Monamele GC; Njankouo-Ripa M; Fatawou Modiyinji A; Ngoupo PA; Boyomo O; Njouom R
Influenza Other Respir Viruses; 2023 Mar; 17(3):e13131. PubMed ID: 36991539
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 and self-medication in Cameroon: a mathematical model.
Kong JD; Tchuendom RF; Adeleye SA; David JF; Admasu FS; Bakare EA; Siewe N
J Biol Dyn; 2021 Dec; 15(1):137-150. PubMed ID: 33538240
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000).
Fokam J; Alteri C; Colagrossi L; Genevieve AM; Takou D; Ndjolo A; Colizzi V; Ndembi N; Perno CF
PLoS One; 2022; 17(9):e0273818. PubMed ID: 36129931
[TBL] [Abstract][Full Text] [Related]
10. Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon.
Ndongo FA; Guichet E; Mimbé ED; Ndié J; Pelloquin R; Varloteaux M; Esemu L; Mpoudi-Etame M; Lamare N; Edoul G; Wouambo RK; Djomsi DM; Tongo M; Tabala FN; Dongmo RK; Diallo MSK; Bouillin J; Thaurignac G; Ayouba A; Peeters M; Delaporte E; Bissek AZ; Mpoudi-Ngolé E
Emerg Infect Dis; 2022 Jun; 28(6):1233-1236. PubMed ID: 35470795
[TBL] [Abstract][Full Text] [Related]
11. Home testing for SARS-CoV-2 and impact on surveillance in New York State.
Mitchell EC; Nguyen T; Boulais M; Ravi Brenner I; Dorabawila V; Hoen R; Li Y; Cavazos M; Levine B; Anderson BJ; Battles H; Brissette I; Backenson B; Lutterloh E; Bauer UE; Rosenberg ES
Ann Epidemiol; 2024 Mar; 91():74-81. PubMed ID: 37995986
[TBL] [Abstract][Full Text] [Related]
12. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators
Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
[TBL] [Abstract][Full Text] [Related]
13. Lessons from the Ebola epidemics and their applications for COVID-19 pandemic response in sub-Saharan Africa.
Afolabi MO; Folayan MO; Munung NS; Yakubu A; Ndow G; Jegede A; Ambe J; Kombe F
Dev World Bioeth; 2021 Mar; 21(1):25-30. PubMed ID: 32654261
[TBL] [Abstract][Full Text] [Related]
14. Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2.
Huisman JS; Scire J; Angst DC; Li J; Neher RA; Maathuis MH; Bonhoeffer S; Stadler T
Elife; 2022 Aug; 11():. PubMed ID: 35938911
[TBL] [Abstract][Full Text] [Related]
15. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting in-hospital all-cause mortality in COVID 19 patients at the Laquintinie Hospital Douala, Cameroon.
Ebongue MSN; Lemogoum D; Endale-Mangamba LM; Barche B; Eyoum C; Simo Yomi SH; Mekolo D; Ngambi V; Doumbe J; Sike CM; Boombhi J; Ngondi G; Biholong C; Kamdem J; Mbenoun L; Tegeu CK; Djomou A; Dzudie A; Kamdem F; Ntock FN; Mfeukeu LK; Sobngwi E; Penda I; Njock R; Essomba N; Yombi JC; Ngatchou W
Travel Med Infect Dis; 2022; 47():102292. PubMed ID: 35307539
[TBL] [Abstract][Full Text] [Related]
17. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates.
Lundberg AL; Lorenzo-Redondo R; Hultquist JF; Hawkins CA; Ozer EA; Welch SB; Prasad PVV; Achenbach CJ; White JI; Oehmke JF; Murphy RL; Havey RJ; Post LA
JMIR Public Health Surveill; 2022 Jun; 8(6):e37377. PubMed ID: 35500140
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological situation of SARS-CoV-2 infection in Douala, the most populated and highly heterogeneous town of Cameroon: a post-vaccination update.
Moguem Soubgui AF; Embolo Enyegue EL; Kojom Foko LP; Ndeme Mboussi WS; Deutou Hogoue G; Mbougang SP; Sanda SM; Fotso Chidjou IU; Fotso VF; Nzogang Tchonet SA; Medi Sike C; Koanga Mogtomo ML
Acta Trop; 2023 May; 241():106864. PubMed ID: 36849093
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
